Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $12,176 | 6 | 85.5% |
| Food and Beverage | $2,063 | 58 | 14.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intuitive Surgical, Inc. | $12,578 | 10 | $0 (2021) |
| Boston Scientific Corporation | $326.63 | 7 | $0 (2024) |
| Medtronic USA, Inc. | $220.87 | 11 | $0 (2020) |
| NeoTract Inc. | $188.44 | 3 | $0 (2020) |
| Teleflex LLC | $165.09 | 2 | $0 (2024) |
| Coloplast Corp | $133.70 | 5 | $0 (2023) |
| Janssen Biotech, Inc. | $133.68 | 5 | $0 (2024) |
| Astellas Pharma US Inc | $103.97 | 2 | $0 (2018) |
| Medtronic, Inc. | $102.30 | 2 | $0 (2024) |
| ABBVIE INC. | $43.06 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $559.07 | 21 | Teleflex LLC ($165.09) |
| 2023 | $20.25 | 1 | Coloplast Corp ($20.25) |
| 2022 | $21.52 | 1 | Olympus America Inc. ($21.52) |
| 2021 | $12,554 | 10 | Intuitive Surgical, Inc. ($12,453) |
| 2020 | $121.39 | 5 | Intuitive Surgical, Inc. ($44.39) |
| 2019 | $151.87 | 6 | Medtronic USA, Inc. ($151.87) |
| 2018 | $387.04 | 7 | Boston Scientific Corporation ($117.59) |
| 2017 | $423.48 | 13 | BOSTON SCIENTIFIC CORPORATION ($186.62) |
All Payment Transactions
64 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Oncology | ||||||
| 11/26/2024 | Daiichi Sankyo Inc. | Vanflyta (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Oncology | ||||||
| 10/23/2024 | Stemline Therapeutics Inc. | ELZONRIS (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Oncology | ||||||
| 10/17/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: ONCOLOGY | ||||||
| 09/04/2024 | Cook Medical LLC | S~CURVE (Device) | Food and Beverage | Cash or cash equivalent | $22.14 | General |
| Category: Urology | ||||||
| 08/08/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Oncology | ||||||
| 08/01/2024 | Janssen Biotech, Inc. | CARVYKTI (Drug) | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: Oncology | ||||||
| 07/22/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Oncology | ||||||
| 07/18/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/27/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $147.60 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 06/20/2024 | Janssen Biotech, Inc. | CARVYKTI (Drug) | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: Oncology | ||||||
| 06/04/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Oncology | ||||||
| 05/29/2024 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $26.49 | General |
| Category: Oncology | ||||||
| 05/07/2024 | Boston Scientific Corporation | Advantage System (Device) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: Advantage_URO | ||||||
| 04/30/2024 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Oncology | ||||||
| 04/25/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Education | In-kind items and services | $68.00 | General |
| Category: Oncology | ||||||
| 04/18/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Oncology | ||||||
| 04/16/2024 | Teleflex LLC | — | Food and Beverage | In-kind items and services | $17.49 | General |
| 04/09/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $30.60 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 04/04/2024 | Janssen Biotech, Inc. | — | Food and Beverage | In-kind items and services | $25.43 | General |
| 07/25/2023 | Coloplast Corp | Altis (Device) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Women's Health | ||||||
| 05/17/2022 | Olympus America Inc. | — | Food and Beverage | In-kind items and services | $21.52 | General |
| 10/13/2021 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Education | Cash or cash equivalent | $4,000.00 | General |
| Category: SURGERY | ||||||
| 10/13/2021 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | Cash or cash equivalent | $150.00 | General |
| Category: SURGERY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,111 | 1,227 | $447,429 | $107,325 |
| 2022 | 26 | 1,977 | 2,308 | $690,097 | $231,585 |
| 2021 | 31 | 2,339 | 2,790 | $826,747 | $277,761 |
| 2020 | 30 | 2,284 | 2,697 | $697,882 | $227,005 |
All Medicare Procedures & Services
112 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 180 | 195 | $51,956 | $16,786 | 32.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 137 | 137 | $59,464 | $15,578 | 26.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 186 | 206 | $37,520 | $11,246 | 30.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 61 | 65 | $28,979 | $11,156 | 38.5% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 12 | 66 | $83,672 | $9,243 | 11.0% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2023 | 11 | 11 | $21,274 | $6,494 | 30.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 79 | 79 | $22,950 | $6,062 | 26.4% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 21 | 21 | $16,378 | $5,484 | 33.5% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 14 | 14 | $11,608 | $4,472 | 38.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 28 | 29 | $25,131 | $3,400 | 13.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 30 | 30 | $17,142 | $2,874 | 16.8% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 15 | 15 | $7,728 | $2,654 | 34.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 17 | 17 | $9,169 | $1,875 | 20.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 18 | $9,382 | $1,753 | 18.7% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 16 | 16 | $7,099 | $1,752 | 24.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 13 | $5,173 | $1,744 | 33.7% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 14 | 14 | $12,678 | $1,375 | 10.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 18 | $4,670 | $1,166 | 25.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 17 | $2,251 | $642.74 | 28.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 75 | 75 | $9,129 | $503.26 | 5.5% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 12 | 12 | $772.00 | $299.64 | 38.8% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 14 | 14 | $510.00 | $273.84 | 53.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 57 | 61 | $1,586 | $208.01 | 13.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 65 | 73 | $657.00 | $160.60 | 24.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 11 | $551.00 | $125.07 | 22.7% |
About Dr. Adam Mues, MD
Dr. Adam Mues, MD is a Urology healthcare provider based in Lincoln, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2007. The National Provider Identifier (NPI) number assigned to this provider is 1871700054.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adam Mues, MD has received a total of $14,239 in payments from pharmaceutical and medical device companies, with $559.07 received in 2024. These payments were reported across 64 transactions from 21 companies. The most common payment nature is "Education" ($12,176).
As a Medicare-enrolled provider, Mues has provided services to 7,711 Medicare beneficiaries, totaling 9,022 services with total Medicare billing of $843,676. Data is available for 4 years (2020–2023), covering 112 distinct procedure/service records.
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Lincoln, NE
- Active Since 05/17/2007
- Last Updated 03/21/2024
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1871700054
Products in Payments
- Da Vinci Surgical System (Device) $12,578
- INTERSTIM (Device) $323.17
- AMS (Device) $210.84
- UROLIFT (Device) $147.60
- UroLift (Device) $121.56
- ERLEADA (Drug) $84.07
- AMS 700 (Device) $82.60
- Urolift - UL400 (Device) $66.88
- TITAN (Device) $65.90
- TAGRISSO (Drug) $30.85
- SpeediCath (Device) $29.57
- KRAZATI (Drug) $26.49
- Androgel (Drug) $26.34
- CARVYKTI (Drug) $24.18
- Advantage System (Device) $22.42
- S~CURVE (Device) $22.14
- Altis (Device) $20.25
- Olympus Camera Heads (Device) $18.39
- CONTINENCE CARE (Device) $17.98
- Vanflyta (Drug) $17.60
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Lincoln
Dr. Antonio Beltran, Md, MD
Urology — Payments: $39,152
Dr. Lance Wiebusch, Md, MD
Urology — Payments: $25,945
David Wiltfong, Md, MD
Urology — Payments: $7,575
Brandon Henslee, Md, MD
Urology — Payments: $6,304
Christopher Larson, Md, MD
Urology — Payments: $5,190
Andrew Lepinski, Md, MD
Urology — Payments: $4,470